Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Oxygenta Pharmaceutical's OCF Margin % or its related term are showing as below:
BOM:524636'
s OCF Margin % Range Over the Past 10 Years
Min: -38.01 Med: -4.2 Max: 9.97
Current: -20.58
During the past 13 years, the highest OCF Margin % of Oxygenta Pharmaceutical was 9.97%. The lowest was -38.01%. And the median was -4.20%.
BOM:524636's OCF Margin % is ranked worse than 87.03% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs BOM:524636: -20.58
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxygenta Pharmaceutical OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Oxygenta Pharmaceutical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxygenta Pharmaceutical (BOM:524636) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oxygenta Pharmaceutical and its competitors. According to the industry distribution chart, Oxygenta Pharmaceutical ranks #839 out of 964 companies in the Drug Manufacturers industry, placing it in the top 87%.
Is Oxygenta Pharmaceutical's OCF Margin % too high?
Oxygenta Pharmaceutical's current OCF Margin % is 0.00%. Based on the distribution chart, Oxygenta Pharmaceutical ranks #839 out of 964 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Oxygenta Pharmaceutical has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oxygenta Pharmaceutical's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Oxygenta Pharmaceutical ranks #839 out of 964 companies for OCF Margin %. This places Oxygenta Pharmaceutical in the lower half of its industry. The industry median OCF Margin % is 10.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oxygenta Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxygenta Pharmaceutical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxygenta Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Oxygenta Pharmaceutical (BOM:524636) is currently considered Possible Value Trap. The stock's GF Value™ is ₹84.23, compared to a current price of ₹51.25 — trading 39.2% below its estimated fair value. The current OCF Margin % is 0.00%. Oxygenta Pharmaceutical's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Oxygenta Pharmaceutical (BOM:524636), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxygenta Pharmaceutical (BOM:524636) Overvalued in 2026?
Based on GuruFocus' analysis, Oxygenta Pharmaceutical stock appears to be undervalued.
The current stock price of ₹51.25 is trading 39.2% below its estimated GF Value™ of ₹84.23.
GuruFocus considers Oxygenta Pharmaceutical to be Possible Value Trap.
Key valuation signals for BOM:524636:
OCF Margin %: 0.00%
GF Value™: ₹84.23 vs. price of ₹51.25 (39.2% below fair value)
No single metric tells the full story. See the BOM:524636 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of is engaged in manufacturing and selling of Pharmaceutical, medical, and veterinary preparations. The Company has one reportable segment, which is Pharmaceutical. The group carries out its business operations within India.
42GF Score
Get the complete analysis for BOM:524636
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524636 has been successfully added to your 
